Tran M, Wood E, Kerr T, Patterson S, Bangsberg D, Dong H, Guillemi S, Montaner JSG, Milloy MJ Increases in CD4+ cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada Antivir Ther, 2017. PubMed

Luongo N, Dong H, Kerr T, Milloy MJ, Hayashi K, Richardson L Income generation and attitudes towards addiction treatment among people who use illicit drugs in a Canadian setting Addict Behav, 2017. PubMed

Nolan S, Klimas J, Wood E Alcohol use in opioid agonist treatment Addict Sci Clin Pract, 2016. PubMed

Socías ME, Ahamad K An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders CMAJ, 2016. PubMed

Socías ME, Volkow N, Wood E Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care? Addiction, 2016. PubMed

Zivanovic R, Wood E, Nolan S Naloxone infusion in the setting of an unknown ingestion: a case report Can J Addict, 2016. Link

Rieb LM, Norman WV, Martin RE, Berkowitz J, Wood E, McNeil R, Milloy MJ Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon Pain, 2016. PubMed

Lake S, Milloy MJ, Dong H, Hayashi K, Wood E, Kerr T, DeBeck K Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs Drug Alcohol Depend, 2016. PubMed

Krebs E, Wang L, Olding M, DeBeck K, Hayashi K, Milloy MJ, Wood E, Nosyk B, Richardson L Increased drug use and the timing of social assistance receipt among people who use illicit drugs Soc Sci Med, 2016. PubMed

Lake S, Kerr T, Buxton J, Guillemi S, Parashar S, Montaner J, Wood E, Milloy MJ Prescription opioid injection among HIV-positive people who inject drugs in a Canadian setting AIDS Behav, 2016. PubMed